Medicine
167 Articles & Excerpts
User Fees for Faster Drug Reviews?
by Food and Drug Administration (FDA)
Resources provided by user fees helped FDA revive its drug and biologic new product review . But eliminating review delays has not eliminated criticism of the program.
The End of One-Size-Fits-All Medicine?: Personalized Medicine Showing Promise
by National Institute of Health
Most of the time, doctors can be pretty sure that the medicine they give you is going to help. But sometimes they have to just wait and see. The fact is, people don't all respond the same way to medications.
Safe Use of Medicines
by Health Canada
Prescription drugs and over-the-counter medicines can help cure diseases and make you feel better. However, all medicines should be used carefully. All medicines carry some risk. Your body can have a mild reaction to a medicine, such as a minor rash
User Fees for Faster Drug Reviews? : Part 2
by Food and Drug Administration (FDA)
A major concern focuses on the perceived impact of industry money, and there are some who express apprehension about the arrangement. In its report from the Government Performance Project in March 2000, the Maxwell School of Public Administration
User Fees to Fund Faster Reviews : Part 2
by Food and Drug Administration (FDA)
The idea of FDA user fees resurfaced beginning in 1982 but failed to gain significant support. In 1992, things changed. As budget proceedings for FY 1993 began, FDA Commissioner David A. Kessler, M.D., testified before Congress that the user fee issue was
Medicare Insurance Covers Clinical Trials: Another Reason to Participate
by National Institute of Health
Are you over 65 and thinking about participating in a clinical trial? If so, there's an important change in your health insurance you should know about. Your Medicare health insurance will now cover many of the routine costs of clinical trials.
Cancer Drugs: Risks and Benefits
by Food and Drug Administration (FDA)
Few deliberations have greater bearing on human health than when the Food and Drug Administration weighs the risks and benefits of drugs designed to treat life-threatening diseases, such as cancer.
| 